» Articles » PMID: 35955975

Macrophages, Low-Grade Inflammation, Insulin Resistance and Hyperinsulinemia: A Mutual Ambiguous Relationship in the Development of Metabolic Diseases

Overview
Journal J Clin Med
Specialty General Medicine
Date 2022 Aug 12
PMID 35955975
Authors
Affiliations
Soon will be listed here.
Abstract

Metabolic derangement with poor glycemic control accompanying overweight and obesity is associated with chronic low-grade inflammation and hyperinsulinemia. Macrophages, which present a very heterogeneous population of cells, play a key role in the maintenance of normal tissue homeostasis, but functional alterations in the resident macrophage pool as well as newly recruited monocyte-derived macrophages are important drivers in the development of low-grade inflammation. While metabolic dysfunction, insulin resistance and tissue damage may trigger or advance pro-inflammatory responses in macrophages, the inflammation itself contributes to the development of insulin resistance and the resulting hyperinsulinemia. Macrophages express insulin receptors whose downstream signaling networks share a number of knots with the signaling pathways of pattern recognition and cytokine receptors, which shape macrophage polarity. The shared knots allow insulin to enhance or attenuate both pro-inflammatory and anti-inflammatory macrophage responses. This supposedly physiological function may be impaired by hyperinsulinemia or insulin resistance in macrophages. This review discusses the mutual ambiguous relationship of low-grade inflammation, insulin resistance, hyperinsulinemia and the insulin-dependent modulation of macrophage activity with a focus on adipose tissue and liver.

Citing Articles

Promotion of NLRP3 autophagosome degradation by PV-K nanodevice for protection against macrophage pyroptosis-mediated lung injury.

Fan Y, Mei J, Shen Y, Gao Y, Zhao L, Meng S J Nanobiotechnology. 2025; 23(1):148.

PMID: 40016743 PMC: 11866711. DOI: 10.1186/s12951-025-03219-y.


ACSS2 and metabolic diseases: from lipid metabolism to therapeutic target.

El-Kurjieh A, Al-Arab R, Hachem Q, Ibrahim J, Kobeissy P Lipids Health Dis. 2025; 24(1):74.

PMID: 40001058 PMC: 11853604. DOI: 10.1186/s12944-025-02491-z.


Dapagliflozin Improves High-Fat Diet-Induced Cognitive Impairment in Female Mice.

Chen X, Fan M, Xiao Z, Xiong X Brain Behav. 2025; 15(2):e70361.

PMID: 39972998 PMC: 11839776. DOI: 10.1002/brb3.70361.


Vanillic acid as a promising intervention for metabolic syndrome: Preclinical studies.

Rahbardar M, Ferns G, Ghayour Mobarhan M Iran J Basic Med Sci. 2025; 28(2):141-150.

PMID: 39850111 PMC: 11756736. DOI: 10.22038/ijbms.2024.81709.17680.


Diabetic Glycation of Human Serum Albumin Affects Its Immunogenicity.

Croes C, Chrysanthou M, Hoppenbrouwers T, Wichers H, Keijer J, Savelkoul H Biomolecules. 2025; 14(12.

PMID: 39766199 PMC: 11673269. DOI: 10.3390/biom14121492.


References
1.
Wu J, Tseng Y, Xu C, Neubert T, White M, Hubbard S . Structural and biochemical characterization of the KRLB region in insulin receptor substrate-2. Nat Struct Mol Biol. 2008; 15(3):251-8. DOI: 10.1038/nsmb.1388. View

2.
Bonnardel J, TJonck W, Gaublomme D, Browaeys R, Scott C, Martens L . Stellate Cells, Hepatocytes, and Endothelial Cells Imprint the Kupffer Cell Identity on Monocytes Colonizing the Liver Macrophage Niche. Immunity. 2019; 51(4):638-654.e9. PMC: 6876284. DOI: 10.1016/j.immuni.2019.08.017. View

3.
Amano S, Cohen J, Vangala P, Tencerova M, Nicoloro S, Yawe J . Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation. Cell Metab. 2013; 19(1):162-171. PMC: 3931314. DOI: 10.1016/j.cmet.2013.11.017. View

4.
Xia S, Wang Z, Sun S, Su Y, Li Z, Shao J . Endoplasmic reticulum stress and protein degradation in chronic liver disease. Pharmacol Res. 2020; 161:105218. DOI: 10.1016/j.phrs.2020.105218. View

5.
Saltiel A, Olefsky J . Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017; 127(1):1-4. PMC: 5199709. DOI: 10.1172/JCI92035. View